Friday’s Midday Stock Update: Navios Maritime Partners Lp (NMM), Cormedix Inc (CRMD), Acelrx (ACRX), OncoSec Medical (ONCS), CDTi Advanced Materials Inc (CDTI)

By Carrie Williams

So far Friday, November 23, NASDAQ is up 0.81% and the S&P is up 0.83%. Here are this morning’s most active stocks: Navios Maritime Partners Lp (NMMResearch Report), Cormedix Inc (CRMDResearch Report), Acelrx (ACRXResearch Report), OncoSec Medical (ONCSResearch Report) and CDTi Advanced Materials Inc (CDTIResearch Report).

Navios Maritime Partners Lp is up 14.29% in midday trading to $1.36. Shares opened today at $1.19. The company has a 52-week low of $1.16 and a 52-week high of $0.00.

Cormedix Inc is up 13.71% in midday trading to $1.41. Shares opened today at $1.24. The company has a 52-week low of $0.17 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.00, marking a 141.94% potential upside from current levels. In a report issued on October 15, H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on CRMD, with a price target of $3, which represents a potential upside of 142% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Cormedix Inc has been positive based on 13 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Acelrx is up 9.75% in midday trading to $3.78. Shares opened today at $3.44. The company has a 52-week low of $1.65 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $8.67, marking a 152.03% potential upside from current levels. In a report issued on November 6, H.C. Wainwright analyst Ed Arce maintained a Buy rating on ACRX, with a price target of $9, which represents a potential upside of 162% from where the stock is currently trading. Separately, on November 5, Oppenheimer’s Leland Gershell reiterated a Hold rating on the stock . In the last 30 days, insiders purchased $123.1K worth of ACRX shares. Over the last 3 months, the insider sentiment on Acelrx has been positive based on 18 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

OncoSec Medical is up 9.41% in midday trading to $0.93. Shares opened today at $0.85. The company has a 52-week low of $0.68 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.00, marking a 252.94% potential upside from current levels. In a report issued on November 16, Maxim Group analyst Jason McCarthy maintained a Buy rating on ONCS, with a price target of $5, which implies an upside of 488% from current levels. Separately, on November 7, H.C. Wainwright’s Ram Selvaraju downgraded the stock to Hold and has a price target of $1. In the last 30 days, insiders purchased $9,100 worth of ONCS shares. Over the last 3 months, the insider sentiment on OncoSec Medical has been positive based on 9 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

CDTi Advanced Materials Inc is up 9.34% in midday trading to $0.58. Shares opened today at $0.53. The company has a 52-week low of $0.30 and a 52-week high of $0.00.

Trending Stocks Based on Insider Activity >>